252 related articles for article (PubMed ID: 31934895)
1. Cancer-associated fibroblasts in cholangiocarcinoma.
Vaquero J; Aoudjehane L; Fouassier L
Curr Opin Gastroenterol; 2020 Mar; 36(2):63-69. PubMed ID: 31934895
[TBL] [Abstract][Full Text] [Related]
2. The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicine.
Rimassa L; Personeni N; Aghemo A; Lleo A
J Autoimmun; 2019 Jun; 100():17-26. PubMed ID: 30862450
[TBL] [Abstract][Full Text] [Related]
3. Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations.
Affo S; Nair A; Brundu F; Ravichandra A; Bhattacharjee S; Matsuda M; Chin L; Filliol A; Wen W; Song X; Decker A; Worley J; Caviglia JM; Yu L; Yin D; Saito Y; Savage T; Wells RG; Mack M; Zender L; Arpaia N; Remotti HE; Rabadan R; Sims P; Leblond AL; Weber A; Riener MO; Stockwell BR; Gaublomme J; Llovet JM; Kalluri R; Michalopoulos GK; Seki E; Sia D; Chen X; Califano A; Schwabe RF
Cancer Cell; 2021 Jun; 39(6):866-882.e11. PubMed ID: 33930309
[TBL] [Abstract][Full Text] [Related]
4. Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma progression and therapeutic resistance.
Ravichandra A; Bhattacharjee S; Affò S
Adv Cancer Res; 2022; 156():201-226. PubMed ID: 35961700
[TBL] [Abstract][Full Text] [Related]
5. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium.
Gentilini A; Pastore M; Marra F; Raggi C
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30249019
[TBL] [Abstract][Full Text] [Related]
6. Photothermal Depletion of Cancer-Associated Fibroblasts Normalizes Tumor Stiffness in Desmoplastic Cholangiocarcinoma.
Nicolás-Boluda A; Vaquero J; Laurent G; Renault G; Bazzi R; Donnadieu E; Roux S; Fouassier L; Gazeau F
ACS Nano; 2020 May; 14(5):5738-5753. PubMed ID: 32338871
[TBL] [Abstract][Full Text] [Related]
7. Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma.
Ying F; Chan MSM; Lee TKW
Cell Mol Gastroenterol Hepatol; 2023; 15(4):985-999. PubMed ID: 36708970
[TBL] [Abstract][Full Text] [Related]
8. Tumor immune microenvironment and the current immunotherapy of cholangiocarcinoma (Review).
Yang S; Zou R; Dai Y; Hu Y; Li F; Hu H
Int J Oncol; 2023 Dec; 63(6):. PubMed ID: 37888583
[TBL] [Abstract][Full Text] [Related]
9. The role of tumour microenvironment: a new vision for cholangiocarcinoma.
Chen Z; Guo P; Xie X; Yu H; Wang Y; Chen G
J Cell Mol Med; 2019 Jan; 23(1):59-69. PubMed ID: 30394682
[TBL] [Abstract][Full Text] [Related]
10. Targeting cholangiocarcinoma.
Mertens JC; Ilyas SI; Gores GJ
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1454-1460. PubMed ID: 28844952
[TBL] [Abstract][Full Text] [Related]
11. Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).
Banales JM; Cardinale V; Carpino G; Marzioni M; Andersen JB; Invernizzi P; Lind GE; Folseraas T; Forbes SJ; Fouassier L; Geier A; Calvisi DF; Mertens JC; Trauner M; Benedetti A; Maroni L; Vaquero J; Macias RI; Raggi C; Perugorria MJ; Gaudio E; Boberg KM; Marin JJ; Alvaro D
Nat Rev Gastroenterol Hepatol; 2016 May; 13(5):261-80. PubMed ID: 27095655
[TBL] [Abstract][Full Text] [Related]
12. SERPINE1: Role in Cholangiocarcinoma Progression and a Therapeutic Target in the Desmoplastic Microenvironment.
Czekay RP; Higgins CE; Aydin HB; Samarakoon R; Subasi NB; Higgins SP; Lee H; Higgins PJ
Cells; 2024 May; 13(10):. PubMed ID: 38786020
[TBL] [Abstract][Full Text] [Related]
13. The tumour microenvironment and immune milieu of cholangiocarcinoma.
Fabris L; Perugorria MJ; Mertens J; Björkström NK; Cramer T; Lleo A; Solinas A; Sänger H; Lukacs-Kornek V; Moncsek A; Siebenhüner A; Strazzabosco M
Liver Int; 2019 May; 39 Suppl 1(Suppl 1):63-78. PubMed ID: 30907492
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity, crosstalk, and targeting of cancer-associated fibroblasts in cholangiocarcinoma.
Cantallops Vilà P; Ravichandra A; Agirre Lizaso A; Perugorria MJ; Affò S
Hepatology; 2024 Apr; 79(4):941-958. PubMed ID: 37018128
[TBL] [Abstract][Full Text] [Related]
15. Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.
Cao H; Huang T; Dai M; Kong X; Liu H; Zheng Z; Sun G; Sun G; Rong D; Jin Z; Tang W; Xia Y
Int J Biol Sci; 2022; 18(14):5369-5390. PubMed ID: 36147461
[TBL] [Abstract][Full Text] [Related]
16. The IGF2/IR/IGF1R Pathway in Tumor Cells and Myofibroblasts Mediates Resistance to EGFR Inhibition in Cholangiocarcinoma.
Vaquero J; Lobe C; Tahraoui S; Clapéron A; Mergey M; Merabtene F; Wendum D; Coulouarn C; Housset C; Desbois-Mouthon C; Praz F; Fouassier L
Clin Cancer Res; 2018 Sep; 24(17):4282-4296. PubMed ID: 29716918
[No Abstract] [Full Text] [Related]
17. Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells.
Thongchot S; Ferraresi A; Vidoni C; Loilome W; Yongvanit P; Namwat N; Isidoro C
Cancer Lett; 2018 Aug; 430():160-171. PubMed ID: 29802929
[TBL] [Abstract][Full Text] [Related]
18. HIPK2 role in the tumor-host interaction: Impact on fibroblasts transdifferentiation CAF-like.
Garufi A; Traversi G; Cirone M; D'Orazi G
IUBMB Life; 2019 Dec; 71(12):2055-2061. PubMed ID: 31414572
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in the Pancreatic Cancer Tumor Microenvironment-The Double-Edged Sword of Cancer-Associated Fibroblasts.
Pfeifer E; Burchell JM; Dazzi F; Sarker D; Beatson R
Cells; 2021 Jul; 10(7):. PubMed ID: 34359823
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinoma: current concepts and insights.
Gores GJ
Hepatology; 2003 May; 37(5):961-9. PubMed ID: 12717374
[No Abstract] [Full Text] [Related]
[Next] [New Search]